GW PHARMACEUTICALS
GW is a biopharmaceutical company focused on discovering, developing, and commercializing novel therapeutics from its proprietary cannabinoid product platform in a broad range of disease areas. The Company's lead product, EPIDIOLEX (cannabidiol) oral solution, is commercialized in the U.S. by its U.S. subsidiary Greenwich Biosciences for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS), Dravet syndrome, or tuberous sclerosis complex (TSC) in patients one year of age and ol... der. This product has received approval in the European Union under the tradename EPIDYOLEX for the adjunctive treatment of seizures associated with LGS or Dravet syndrome in conjunction with clobazam in patients two years and older and is under EMA review for the treatment of TSC. The Company has a deep pipeline of additional cannabinoid product candidates, in particular nabiximols, for which the Company is advancing multiple late-stage clinical programs in order to seek FDA approval in the treatment of spasticity associated with multiple sclerosis and spinal cord injury. The Company has additional cannabinoid product candidates in clinical trials for autism and schizophrenia.
GW PHARMACEUTICALS
Social Links:
Industry:
Biotechnology Cannabis Health Care Pharmaceutical Therapeutics
Founded:
1998-01-01
Address:
Histon, Cambridgeshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.gwpharm.com
Total Employee:
501+
Status:
Active
Contact:
+44 (0) 1223 238170
Email Addresses:
[email protected]
Total Funding:
1.22 B USD
Technology used in webpage:
SPF LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Domain Not Resolving Euro Microsoft Exchange Online Amazon IPv6 JsDelivr
Similar Organizations
2A Pharma
2A Pharma is a biopharmaceutical company focused on discovering, developing and commercialising novel, cost effective vaccines.
CANbridge Pharmaceuticals
CANbridge Pharmaceuticals is a bio-pharmaceutical company accelerating development and commercialization of specialty healthcare .
CannAssist International
CannAssist International is a researched-based company focused on creating higher-level alternative therapeutics.
Crinetics Pharmaceuticals
Crinetics is a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics.
Kalapa Clinic
Kalapa Clinic is a medical consultancy pioneered for alternative therapies using cannabinoids.
Keros Therapeutics
Keros is a clinical-stage biopharmaceutical company focusing on the discovery, development, and commercialization of novel treatments.
Scilex Pharmaceuticals
Scilex Pharmaceuticals is an emerging pharmaceutical company focused on acquiring and commercializing late-stage prescription products.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Mentor Capital
Mentor Capital investment in Post-IPO Equity - GW Pharmaceuticals
Official Site Inspections
http://www.gwpharm.com
- Host name: ec2-52-88-89-3.us-west-2.compute.amazonaws.com
- IP address: 52.88.89.3
- Location: Boardman United States
- Latitude: 45.8491
- Longitude: -119.7143
- Metro Code: 810
- Timezone: America/Los_Angeles
- Postal: 97818
More informations about "GW Pharmaceuticals"
GW Pharmaceuticals - Wikipedia
GW Pharmaceuticals was founded in 1998 by doctors Geoffrey Guy and Brian Whittle. That year, they obtained a cultivation license from the United Kingdom Home Office and the MHRA, âĻSee details»
GW Pharmaceuticals - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number +44 (0) 1223 238170 GW is a biopharmaceutical company focused on discovering, developing, and commercializing novel âĻSee details»
GW Pharmaceuticals - Company Profile & Staff Directory
GW Pharmaceuticals is a Pharmaceutical company located in Wiltshire, Wiltshire with 346 employees. Access GW Pharmaceuticals's email format and GW Pharmaceuticals staff âĻSee details»
GW Pharmaceuticals plc - LinkedIn
Sovereign House, Vision Park Chivers Way, Histon Cambridge, CB24 9BZ, GBSee details»
GW Pharmaceuticals plc Management Team | Org Chart
Gwpharm.com; 1 44122326XXXX; View Similar People. Related Companies ELEMIS. 726 $2.3b Which? 907 $107.5m Genomics England. 567 $23m LumiraDx. 760 $421.4m Solent NHS âĻSee details»
GW Pharmaceuticals - Craft
See insights on GW Pharmaceuticals including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
GW Pharmaceuticals Ltd - Company Profile - GlobalData
Website www.gwpharm.com Telephone 44 1223 266800. Industry Pharmaceuticals and Healthcare . Gain access to our premium ...See details»
GW PHARMACEUTICALS LIMITED - Companies House
GW PHARMACEUTICALS LIMITED - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, âĻSee details»
Company GW Pharmaceuticals plc - MarketScreener.com
GW Pharmaceuticals plc: Company profile, business summary, shareholders, managers, financial ratings, industry, sector and market information | Nasdaq: GWPH | NasdaqSee details»
GW Pharmaceuticals (UK) Funding: $1.2B - Medical Startups
Apr 1, 2025 UK | Funding: $1.2B Website: https://www.gwpharm.com GW has established a world leading position in the development of plant-derived cannabinoid therapeutics through its âĻSee details»
GW Pharmaceuticals Ltd. (GW Pharmaceuticals Ltd.) - č¯įŠįŽĄįēŋ_ä¸ âĻ
Apr 1, 2025 The purpose of this study is: * To investigate whether the response to antipsychotic treatment can be enhanced by adding cannabidiol (CBD) to the existing treatment, compared âĻSee details»
GW Pharmaceuticals - Overview, News & Similar companies
GW Pharmaceuticals contact info: Phone number: +44 1223266800 Website: www.gwpharm.co.uk What does GW Pharmaceuticals do? GW Pharmaceuticals' vision is to âĻSee details»
GW Pharmaceuticals 2025 Company Profile: Valuation, Investors ...
Information on acquisition, funding, investors, and executives for GW Pharmaceuticals. Use the PitchBook Platform to explore the full profile.See details»
Jazz Pharmaceuticals Completes Acquisition of GW âĻ
May 5, 2021 The Company plans to provide 2021 financial guidance for the combined Jazz/GW organization within the next 45 days. Under the terms of the agreement, holders of GW ADSs, âĻSee details»
GW Pharmaceuticals plc Company Overview, Contact Details
Oct 2, 2018 New CEO Opportunity Jazz Pharmaceuticals plc is in the process of identifying a successor for the retiring CEO, presenting an opportunity for sales initiatives to build âĻSee details»
GW Pharmaceuticals Plc Locations - Headquarters & Offices
Save hours of research time with a comprehensive Sales Intelligence Solution. Understand how GW Pharmaceuticals Ltd fits into your total addressable market and Ideal Customer Profile.See details»
Gw Pharmaceuticals PLC - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Gw Pharmaceuticals PLC of Carlsbad, CA. Get the latest business insights from Dun & Bradstreet.See details»
GW Pharmaceuticals CEO and Key Executive Team | Craft.co
GW Pharmaceuticals's Director is David Gryska. GW Pharmaceuticals's key executives include David Gryska and 1 others.See details»
Forward Looking Statements - Jazz Pharmaceuticals
This communication contains forward-looking statements regarding Jazz Pharmaceuticals and GW Pharmaceuticals, including, but not limited to, statements related to the proposed âĻSee details»
GW Pharmaceuticals Achieves Positive Results in Phase 2 Proof of ...
The Company has a deep pipeline of additional cannabinoid product candidates which includes compounds in Phase 1 and 2 trials for glioma, schizophrenia and epilepsy. For further âĻSee details»